Imagion has released the Quarterly Activity Report and Appendix 4C for the period ending on 30 June 2022.
The announcement highlights:
- MagSense® HER2 imaging agent passes stability milestone
- Research collaboration with University of Sydney expands brain cancer project
- Research agreement with Massachusetts General Hospital focuses on MRI
Read the full announcements here: Quarterly Activity Report and Appendix 4C